EGFR and non-small cell lung carcinoma: It is worth noting that NSCLC harboring EGFR activating mutations have been reported to demonstrate decreased levels of ERCC1 expression.11, 12 Most of these activating mutations occurred in EGFR gene exons 19 to 21 which encode the tyrosine kinase domain.